P ediatric pulmonary arterial hypertension (PAH) is a disease associated with high morbidity and mortality. [1] [2] [3] Right ventricular (RV) dysfunction serves as an important predictor of PAH severity and outcome in both pediatric and adult populations. 4, 5 However, studies of ventricular interdependence have shown that PAH is further complicated by evidence of left ventricular (LV) dysfunction, which may be predictive of poor outcomes in adult PAH populations. 6 Similar findings of critical RV-LV interdependence have been recently recognized in children with PAH, 7,8 further suggesting that altered LV performance can accompany progressive changes in RV function in pediatric PAH as well. However, mechanisms that influence LV performance, such as impaired preload, LV diastolic dysfunction, and other factors, remain incompletely understood.
Aortic Stiffness in Pediatric PAH
Mechanically induced apparent aortic stiffness because of these vascular interactions could potentially increase LV afterload, further compromising LV function in children with PAH.
Consequently, in this study, we sought to determine whether aortic stiffness is increased in children with PAH and whether changes in indices of aortic stiffness are directly associated with the geometry of the MPA and with LV functional performance. These studies were performed with noninvasive magnetic resonance imaging (MRI) techniques that enable assessment of vascular stiffness, including indices based on measurements of pulse wave velocity (PWV), vascular strain, and distensibility. We hypothesized that (1) the ascending aorta of PAH patients will show signs of vascular stiffness and (2) that increased aortic stiffness will be reflective of pulmonary arterial dimensions and LV performance. Greater understanding of the overall PAH pathophysiology in pediatric patients may assist in development of more comprehensive clinical assessments, including disease severity, changes in function over time, and guidance of specific therapies for this population.
Methods
This study was performed with the approval of the Colorado MultiInstitutional Review Board, and all subjects provided written informed consent. We retrospectively identified consecutive PAH patients seen by the Pulmonary Hypertension Clinic at Children's Hospital Colorado from December 2007 to June 2016, who had comprehensive cardiac magnetic resonance (CMR) performed, which included the use of short-axis stack cine of the ventricles, cine phase-contrast imaging of the ascending aorta, and the MPA. The initial diagnosis of PAH was established after evaluation by our Pulmonary Hypertension Program, which included echocardiograms and a prior cardiac catheterization, according to accepted guidelines. 1 The CMR data sets were selectively chosen to be chronologically closest to either an initial or follow-up cardiac catheterization. The ventricular distress molecules, brain natriuretic peptide (BNP) and N-terminal pro-BNP, were collected at the time of catheterization as indicated by clinical care. We excluded subjects with pulmonary valve or pulmonary arterial stenosis or who had previous surgical intervention on the pulmonary vasculature to focus the study on subjects with native proximal pulmonary vascular conduit anatomy. All control subjects were prospectively recruited through campus advertisement and were included if they did not have any known underlying cardiac, pulmonary, or systemic disease.
CMR Protocol
The acquisition protocol was performed as previously described. 11 A gradient echo ECG-gated sequence was applied to obtain tissue intensity and phase velocity maps using a 1.5 or 3.0 Tesla magnet (Magnetom Avanto, Siemens Medical Solutions, Erlangen, Germany; Ingenia, Philips Medical Systems, Best, The Netherlands). Aortic flow hemodynamic data were acquired using cine phase contrast magnetic resonance imaging (PC-MRI). A single slice covering the ascending aortic plane was chosen to be 1 cm above the sinotubular junction to secure sufficient distance from the aortic root ( Figure 1 ). The acquisition plane for the descending aorta was then ≈3 to 4 cm below the aortic isthmus depending on patient size and age. A typical sequence for free-breathing PC-MRI with Cartesian encoding and retrospective sorting had a temporal resolution of 14 to 28 ms with 15 to 58 phases, echo times of 2.2 to 3.5 ms, matrix 160×256, and flip angle of 25° with 100% of the k-space sampled. Depending on patient size and field of view (128-225×210-360 mm), the cross-sectional pixel resolution was found to be 0.82×0.82 to 1.56×1.56 mm 2 with a slice thickness of 5 mm. Resulting acquisition time varied on heart rate between 1 minute 45 s to 3 minutes. Velocity-encoding values were adjusted according to the maximum velocities encountered during scout sequences to avoid aliasing artifact (typical values ranged from 100 to 200 cm/s).
Standard short-axis images were obtained with coverage of the ventricles from base to apex. Postprocessing analysis of the CMR images was performed using QMass (Medis Medical Imaging Systems; Raleigh, NC), in which volumetric data were manually traced and calculated at end diastole and end systole. Volumetric metrics and ejection fraction were indexed by body surface area values. To include a comprehensive overview of the cardiac and vascular conditions on the systemic side, we also assessed the simplified version of the LV ventricular-vascular coupling ratio based on the CMR-derived volumes, estimated by the ratio of LV end-systolic volume and stroke volume.
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Vascular Stiffness and Hemodynamic Parameters
To control for age-related differences in pediatric weight and height, aortic and MPA geometric dimensions for the ascending aorta and MPA were normalized by body surface area for intergroup variation and further generalized linear model regression analysis. Vessel strain was measured by means of relative area change (RAC) defined as the difference between maximum and minimum areas divided by maximum value: (A max −A min )/A max ×100%. Distensibility for both aortic segments was then computed as the ratio of RAC and pulse pressure. Additionally, to evaluate systemic vascular properties, we computed aortic capacitance assessed by ratio of LV stroke volume and pulse pressure. Blood pressure values were obtained prior to CMR evaluation using pressure oscillometric technique (Invivo, Model 1400 MRI) either in clinic the day prior or in the MRI suite immediately prior to the study commencement. Flow metrics and patient-specific temporal data required for PWV computation were analyzed from time frame-segmented respective magnitude and phase contrast images for both aortic segments, as previously described (Matlab Program; Mathworks, Inc., Natick, MA). 13, 14 Specifically, each temporal phase was segmented using semiautomatic level-set method (Segment, Medviso), where constructed algorithm applies active contour model, which tracks the edges of the vessel wall initialized by a manual delineation in 1 time frame. The following parameters were sampled from patient-specific flow waves: maximum flow (Q max ), maximum velocity (V max ), maximum wall shear stress (WSS max ), and oscillatory shear index, all computed and analyzed as described previously. 13, 15 PWV was measured as a determinant of aortic stiffness. We used the dQ/dA method, previously recognized as a sensitive PWV measure by incorporating temporal variation in flow and luminal area data sets. 16 The PWV was computed as a function of the variation ratio of through-plane aortic flow and cross-sectional aortic area, that is, the slope of the flow-area relation during early systole. The PWV was then calculated from the flow-area plots by using a linear regressional model to create a line fitted to the flow-area curve at early systole as described previously (see Figure 2 ). This technique describes segment-specific evaluation of aortic stiffness, rather than global aortic stiffness. Furthermore, this method overcomes potential spatiotemporal limitations typically associated with standard travel time of flow PWV calculation, which are of high risk in a pediatric population.
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Statistical Analysis
Analyses were performed in SAS (version 9.4 or higher; SAS Institute, Cary, NC). Variables were checked for the distributional assumption of normality using normal plots, in addition to Kolmogorov-Smirnov and Shapiro Wilks tests. Variables that were positively skewed (eg, PWV, RAC, and BNP) were natural log-transformed for the analyses. Demographic and clinical characteristics among children with and without PAH were compared using student t test for normally distributed continuous variables and χ 2 for categorical variables. Additional group comparisons were performed using Kruskal-Wallis test between the PAH-specific World Health Organization functional classes. Generalized linear regression models were used to examine association between aortic stiffness (PWV, RAC, and distensibility) and MPA geometric parameters and risk factors associated with pediatric PAH (LV ejection fraction and ventricular-vascular coupling ratio, mean pulmonary artery pressure, pulmonary vascular resistance index, N-terminal pro-BNP, BNP) adjusted for age and sex. Significance was based on an α level of 0.05.
Results
Demographic and basic hemodynamic measurements are summarized in Table 1 . We identified 42 PAH patients and recruited 26 controls with equivalent age and sex distributions. PAH children patients presented significantly decreased body mass index percentile and body surface area when compared with the controls. The average time between the right heart catheterization and CMR acquisition was 302 days (range 0-401 days). The average mean pulmonary artery pressure and pulmonary vascular resistance index from the chronologically closest catheterization were 44±14 mm Hg and 9±7 Wood units×m 2 , respectively. There were 18 subjects with idiopathic PAH (IPAH), 22 children with PAH associated with congenital heart disease (CHD-PAH), and 2 patients with PAH associated with bronchopulmonary dysplasia. CHD-PAH pathogeneses included atrial septal defects (13; 30.9%), ventricular septal defects (5; 11.9%), and patent ductus arteriosus (5; 11.9%, 2 postligation repair). Furthermore, 5 PAH patients had a shunt present at the time of CMR evaluation (2 with left-to-right shunting). Five PAH patients and 2 controls were excluded from the vascular analysis because of the close proximity of the acquisition plane to aortic root, disabling vessel wall segmentation.
As anticipated, children with PAH had significantly increased RV end-diastolic (138 versus 92 mL/m 2 ; P=0.0005) and end-systolic volumes (84 versus 41 mL/m 2 ; P=0.0008) along with reduced RV ejection fraction (44% versus 58%; P=0.0012). Although no significant variation existed between considered groups between LV volumetric indices (end diastolic, end systolic, and stroke volume), children with PAH presented significantly decreased LV ejection fraction (53% versus 58%; P=0.0231). Systemic pressure metrics did not reveal any significant variability between PAH and control groups. Data from the PAH group showed significantly increased indexed MPA diameter (2.68 versus 1.6 cm/m 2 ; P<0.0001) and increased MPA/aortic diameter ratio measured at systole (1.42 versus 1.07; P<0.0001).
PC-MRI-derived flow data for both aortic segments are summarized in Table 2 . All vascular stiffness measures were significantly different between PAH and control groups in the ascending aorta. PWV (cm/s) was significantly increased in PAH children (3.4 versus 2.3; P=0.0014), indicative of increased ascending aortic stiffness in this disease group. Both geometric-related metrics in the ascending aorta-RAC (%) and distensibility (%/mm Hg)-were significantly decreased in the PAH group (23 versus 29, P<0.0001; and 0.47 versus 0.64, P=0.0242, respectively). Interestingly, these reductions in strain metrics occurred in parallel with decreased maximum aortic area in PAH patients (4.5 versus 5.3 cm 2 ; P=0.0282), whereas the minimal aortic area was similar between both considered groups. The aortic capacitance (stroke volume/ pulse pressure; mL/mm Hg) was similar among considered Figure 3 .
Furthermore, no differences were found in stiffness and hemodynamic metrics between IPAH and CHD-PAH groups. We performed subgroup analysis of ascending aortic stiffness measures to assess the potential variability between IPAH and CHD-PAH groups. Although there was no difference in stiffness metrics between the 2 PAH groups, both groups had decreased RAC and increased PWV when compared with the controls (Figure 4 ). Distensibility and capacitance were not different between groups. Normalized MPA diameter values were increased for both CHD-PAH and IPAH when compared with the controls but were not different between the PAH groups ( Figure 5 ). Similarly, MPA to ascending aortic size ratios were significantly increased for both CHD-PAH and IPAH in comparison with the controls but were not different between PAH cohorts.
A summary of generalized linear regression models between vascular stiffness metrics and standard geometric metrics and PAH risk factors are depicted in Table 3 (reported as beta±standard error). All reported models were adjusted for sex and age. Conventional PAH risk factor variables (mean pulmonary artery pressure, pulmonary vascular resistance index, N-terminal pro-BNP, and BNP) failed to reveal any significant correlations with indices of aortic stiffness (PWV, RAC, and distensibility). However, significant positive correlations existed between the MPA/aortic size ratio and catheterization-derived mean pulmonary artery pressure (0.008±0.002; P=0.0014) and pulmonary vascular resistance index (0.025±0.007; P=0.0019; Figure in the Data Supplement). To investigate the relationship between MPA size and LV systolic function, we correlated MPA/aortic size ratio directly with LVEF and LV ventricularvascular coupling ratio ( Figure 6 ). We found a significant negative linear relationship between MPA/aortic ratios and LVEF (−8.830±3.012; P=0.0005) and positive associations with LV ventricular-vascular coupling (0.323±0.131; P=0.0169).
Discussion
In this study, we have shown that children with PAH have increased apparent aortic stiffness, which was strongly associated with increased MPA size. To our knowledge, this is a first report of reduced functional systemic vascular performance in any PAH population combining evidence from 3 well-accepted indices of stiffness. Furthermore, we found that decreased aortic strain measured by means of RAC is significantly associated with lower LV ejection fraction and higher ventricularvascular coupling ratio. Therefore, increased apparent aortic stiffness, which contributes to systemic afterload, is associated with negative functional consequences in an already compromised LV. Because of the inherent nature of the PAH pathophysiology, past studies in pediatric PAH have focused solely on metrics of RV function and pulmonary vascular stiffness, either in separate or combined fashion. 11, 15, 19, 20 More recently, the increasingly recognized concept of ventricular interdependency has been shown to have important mechanical effects on the LV performance in both adult and pediatric PAH populations. 6, 8, 21 Although the mean LV ejection fraction of our PAH cohort was close to the lower limit of normal, the statistically significant difference point to a compromised LV systolic function as observed in previous multicenter pediatric study. 22 Importantly, in adult and pediatric PAH populations, compromised LV function because of ventricular interdependency was shown to have a clinically prognostic potential. 6, 7 This newly observed effect of potentially existing vascular interdependency might then play important role in overall cardiovascular performance in children with PAH.
Presence of Vascular Interdependency
Although MPA stiffness has been successfully associated with metrics of RV function and hemodynamics, such as flow and shear stress, the reduced aortic distensibility seems to be driven primarily by regional physical effects. Our results indicate that increased MPA size, absolute and indexed to aortic diameter, is associated with increased regional changes in apparent aortic stiffness. All considered stiffness metrics take into account extrinsic geometric vascular properties, and in particular, depressed maximum aortic size seems to be responsible for the majority of altered variables within the PAH group. We speculate that PAHrelated MPA dilatation mechanically impairs the ability of regions of the ascending aorta to fully expand during systole. Further evidence supporting this potential mechanism can be seen from the aortic wall deformation analysis generated from a vascular segmentation process, as shown in Figure 7 . From the representative PAH case, it seems that ascending aorta has more room for expansion in the directions toward the vena cava and right atrium, whereas the range of motion tends to be limited where the aorta is in contact with the MPA. Conversely, the depicted control case shows uniform circumferential expansion. However, standardized comprehensive wall deformation analysis across larger data sets would be required to fully understand potential mechanical suppressing effects arising from the distended MPA.
The argument of locally driven vascular interdependency is also supported by the fact that the stiffness metrics analyzed in the descending aorta failed to show any variability between PAH and control groups. Furthermore, PAH subpopulations considered in this study, CHD-PAH and IPAH, failed to present major variability in the apparent stiffness metrics, yet have major variability differences from control group. Per our results, severity of MPA dilation seems to be uniform among the PAH subgroups (IPAH and CHD-PAH), with similar impact on ascending aortic expansion and overall apparent stiffness. Thus, aortic stiffening does not seem to be a global phenomenon, which might be expected if it were because of other causes, such as pressure overload or systemic inflammation. The descending aorta is in close proximity to the pulmonary vasculature only at the region of the subclavian ligament bypassing the left pulmonary artery. Because our acquisition plane for descending aortic analysis was positioned further distally, we speculate that this particular aortic segment was free from constriction that is potentially caused by the pulmonary vasculature and, therefore, did not reveal any signs of aortic stiffness.
Additional mechanisms might play role in the increased aortic stiffness in PAH. Pulmonary vascular remodeling, including changes in the large proximal vessels, has been associated with the PAH pathobiology, which may be related to increased inflammation because of increased hemodynamic stress. 2, 23, 24 Although PAH-associated inflammatory processes have been previously associated with pulmonary vascular remodeling, changes in tissue remodeling in the aorta has not been examined. Finally, aortic shear hemodynamic metrics, commonly associated with flowmediated endothelial mechanotransduction remodeling, were not altered between the PAH and control groups. 25, 26 However, future longitudinal studies involving thorough analysis of known potential inflammatory vascular remodeling mediators may further explore the potential for tissue remodeling within the aorta in the setting of progressive PAH. The subanalysis of ascending aortic stiffness metrics between pulmonary arterial hypertension associated with congenital heart disease (CHD-PAH), idiopathic pulmonary arterial hypertension (IPAH), and control groups. IPAH and CHD-PAH groups did not present any significant variability in any considered aortic stiffness metrics. However, in the case of relative area change (RAC) and pulse wave velocity (PWV) representing local aortic stiffness, both PAH groups showed significant differences from the control group. No variability existed among considered groups in distensibility and capacitance assessing rather global aortic stiffness. K-W indicates Kruskal-Wallis. Figure 5 . The subanalysis of vessel size metrics between pulmonary arterial hypertension associated with congenital heart disease (CHD-PAH), idiopathic pulmonary arterial hypertension (IPAH), and control groups. Both main pulmonary artery (MPA)-normalized diameter and MPA to ascending aortic ratio revealed significantly higher average values for both considered PAH groups when compared with controls. However, no differences were observed between PAH groups. K-W indicates Kruskal-Wallis. Aortic Stiffness in Pediatric PAH
Aortic Strain and LV Performance Relationship
Although all stiffness metrics showed significant differences between PAH and control groups, only RAC correlated with LV ejection fraction and LV-specific ventricular-vascular coupling ratio. The RAC, unlike PWV, distensibility, and capacitance, is a pure geometric parameter that solely assesses 2-dimensional (area) strain. As a result, RAC can be more reflective of anatomically constraining structures that may reduce vessel expansion to maximum area. 27 On the other hand, PWV, distensibility, and capacitance take into account flow, pressure, and volume changes, respectively, and are then less geometry dependent and can reflect more on true vessel mechanical constitutive changes. 28, 29 Indeed, RAC showed the most significant differences from all considered stiffness metrics in parallel with reduced maximum area in the PAH group. Conversely, peak flow (Q max ), pressure, and volume metrics determining PWV and distensibility, respectively, were not different between control and PAH groups. Additionally, aortic distensibility and capacitance considered to be reflective of global aortic stiffness failed to show any significant intergroup variability, suggesting that reduced apparent ascending aortic stiffness is driven by a local mechanical factors. The local nature of the dilated MPA impinging on the ascending aortic conduit would be most precisely quantified via complete impedance spectra analysis, enabling investigation of local compression-arterial impedance. However, the collection of the impedance spectra in the systemic circulation in this patient population is problematic because of clinical-ethical reasons. Future studies will focus on comprehensive aortic 4D-Flow MRI to assess the qualitative flow patterns along with the energy loss index across the ascending aorta to fully investigate the constriction mechanism.
Therefore, we speculate that changes in apparent ascending aortic stiffness were purely because of anatomic compression by the enlarged, neighboring MPA reflected in the most sensitive way by RAC analysis. The compression of ascending aorta within the pericardial limit by MPA seems to further increase LV afterload, as reflected by association with the LV ejection fraction. Finally, the correlation between RAC and LV ventricularvascular coupling ratio implies that compromised expansion of proximal aorta might have negative afterload-dependent effects on LV performance in pediatric PAH. We also found direct correlation between the MPA to ascending aortic size ratio with LV ejection fraction and ventricular-vascular coupling ratio. Overall, we further speculate that vascular interdependency might add to PAH-induced pathophysiology and add to worsening prognosis associated with LV dysfunction in PAH (Figure 8 ).
Study Limitations
One potential limitation of our study is that the mean time between PC-MRI acquisition and catheterization is variable within our PAH group. We also recognize that some patients underwent the catheterization under anesthesia while being awake for the CMR, which potentially can alter the Data are beta coefficients±SEM (P values). Significant (P<0.05) associations are in bold. All considered models were adjusted for age and sex. BNP indicates brain natriuretic peptide; ESV, end-systolic volume; LVEF, left ventricular ejection fraction; MPA, main pulmonary artery; mPAP, mean pulmonary artery pressure; NTproBNP, N-terminal pro-brain natriuretic peptide; PVRI, pulmonary vascular resistance index; PWV, pulse wave velocity; RAC, relative area change; and VVCR, ventricular-vascular coupling ratio. *Significant differences (P<0.05). hemodynamic state. However, this is unavoidable because vast majority of pediatric catheterizations at our institution is performed under general anesthesia, and within this study, only 6 PAH patients (<8 years) required anesthesia. Future studies will involve synchronized catheterization and noninvasive imaging studies, including echocardiography and 4-dimensional flow MRI, to qualitatively assess the sensitive flow disturbances associated with stiffness-compromised vessels.
PWV assessed by flow-area method works under major assumption of reflection-less free pulse wave in the evaluated vessel region. By evaluating PWV in the ascending and proximal thoracic aorta, the planes of evaluation should be sufficiently distant from resistant arterioles, considered to be the major source of impeding pulse wave. Additionally, we did not observe major reflection from the primary aortic branches usually presented as a major reduction in dQ/dA at the end of initial systole phase. However, this PWV computation method is highly sensitive to segmentation errors (through-plane motion, signal loss at high flow rates, nonuniform flow wave etc.). 16, 30 Another limitation of this study is that included subjects underwent PC-MRI acquisition on 2 different scanning systems. Ideally, the same acquisition sequence and vendor system would have been applied to every subject. Furthermore, given that both systems operate on different magnetic field strengths, intersystem variability is an important consideration. However, the variable field strength has been shown previously to not alter the flow hemodynamic measurements. 31 The heterogeneity of PAH pathogenesis and the body mass index difference between the control and PAH population may have also compromised the overall results.
Conclusions
Pediatric PAH patients have a focal increase in the apparent ascending aortic stiffness as assessed by CMR studies. The apparent aortic stiffness is strongly associated with the degree of distension of the MPA. We speculate that distension of the MPA contributes to aortic stiffness because of its role in limiting full aortic expansion during systole within a restricted space of the thoracic cavity. We propose that in addition to ventricular interdependency, vascular interdependency of the MPA and aorta can potentially have negative effects on LV performance in pediatric PAH, which is primarily because of the mechanical effects of MPA distension. 
